Placebo: NaCl 0.9%

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company, Sanofi

Conditions

Dengue FeverDengue Hemorrhagic Fever

Phase 3

Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia

CompletedNCT01134263

Sanofi Pasteur, a Sanofi CompanyDengue Fever, Dengue Hemorrhagic Fever

Start: 2010-10-05End: 2013-02-28Updated: 2019-07-24

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

CompletedNCT01254422

SanofiDengue Fever, Dengue Hemorrhagic Fever

Start: 2010-12-02End: 2013-01-31Updated: 2022-03-25

Related Papers

Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding

The Journal of Infectious Diseases2017-08-3127 citations